| Literature DB >> 33244121 |
Łukasz Pietrzyk1,2, Marta Denisow-Pietrzyk3, Marcin Czeczelewski4, Konrad Ślizień-Kuczapski4, Kamil Torres3.
Abstract
The objective of the study was to assess the level of testicular cancer (TC) knowledge and awareness as well as the altitude and practice towards testicular self-examination (TSE) among Polish male high school and medical students. An original questionnaire survey was conducted in SE Poland with a representative sample of 1077 male students: 335 from high school and 742 medical students. The results indicate the knowledge about TC epidemiology and the awareness of risk factors responsible for the TC was low. The knowledge of the signs and symptoms of TC was significantly higher among the medical students, compared to the high school students. The level of education was associated with the awareness of methods for early detection and symptoms of TC. A satisfactory level of awareness of the TSE practice was exhibited only by the medical students. The main reason for not performing self-examination was the lack of knowledge and practical skills. The deficits of knowledge of TC in young men should motivate the education policy makers in Poland to implement education in the field of TC issues more widely in high schools. Moreover, cancer prevention modules and/or teaching methods should be improved in medical schools.Entities:
Mesh:
Year: 2020 PMID: 33244121 PMCID: PMC7693263 DOI: 10.1038/s41598-020-77734-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Young men's knowledge of the epidemiological statistics concerning testicular cancer; data are shown as a percentage of correct responses. * p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.001; Current statistics: incidence in Europe: 5.6 per 100,000; age group at risk: 15–44 years; mortality in Europe: 0.4 per 100,000; curability: more than 90% if detected at an early stage[22].
Young men's knowledge of the TC risk factors; data are shown as percentages of selected answers that agreed with the statements regarding the increased risk of cancer development.
| Risk factors for testicular cancer | HS (%) | MS (%) | Pre-clinical MS (%) | Clinical MS (%) | ||
|---|---|---|---|---|---|---|
| Cryptorchidism | 20.9 | 37.9 | < 0.001 | 38.2 | 37.5 | 0.913 |
| Family history of TC | 65.7 | 89.2 | < 0.001 | 91.5 | 86.3 | 0.029 |
| HPV infection | 32.5 | 29.6 | 0.378 | 28.7 | 30.8 | 0.599 |
| High sexual activity | 20.6 | 11.5 | < 0.001 | 11.6 | 11.3 | 0.986 |
| Androgyne intake | 21.8 | 9.0 | < 0.001 | 6.3 | 12.5 | 0.005 |
| Lack of intimate places’ hygiene | 37.9 | 15.6 | < 0.001 | 15.0 | 16.5 | 0.651 |
| Use of heated seats | 22.4 | 26.1 | 0.214 | 35.0 | 14.9 | < 0.001 |
HS, high school students; MS, medical students.
p value: two proportion Z-test - HS versus MS and pre-clinical MS versus clinical MS.
Young men's knowledge of the testicular cancer diagnostic methods; data are shown as percentages of selected answers that agreed with statements regarding the acknowledged methods for TC early-stage detection.
| Method for early detection of testicular cancer | HS (%) | MS (%) | Pre-clinical MS (%) | Clinical MS (%) | ||
|---|---|---|---|---|---|---|
| Medical visit and examination performed by the physician | 70.1 | 67.0 | 0.337 | 62.6 | 73.8 | 0.001 |
| Self-examination | 25.1 | 87.6 | < 0.001 | 89.4 | 85.4 | 0.126 |
| Chest X-ray | 8.1 | 8.1 | 1 | 9.7 | 6.1 | 0.103 |
| Urine test | 36.1 | 16.4 | < 0.001 | 16.7 | 16.2 | 0.932 |
HS, high school students; MS, medical students.
p value: two proportion Z-test - HS versus MS and pre-clinical MS versus clinical MS.
Young men's knowledge of testicular cancer signs and symptoms; data are shown as percentages of selected answers that agreed with statements regarding the common warning signs of TC.
| Symptoms of testicular cancer | HS (%) | MS (%) | Pre-clinical MS (%) | Clinical MS (%) | ||
|---|---|---|---|---|---|---|
| Palpable mass in the scrotum | 50.1 | 84.9 | < 0.001 | 87.0 | 82.3 | 0.099 |
| Induration, feeling of heaviness in the scrotum | 48.1 | 82.3 | < 0.001 | 80.9 | 84.1 | 0.294 |
| Scrotum enlargement | 37.9 | 66.7 | < 0.001 | 67.9 | 65.2 | 0.499 |
| Testicular pain, discomfort | 46.3 | 16.2 | < 0.001 | 19.8 | 11.6 | 0.003 |
HS, high school students; MS, medical students.
p value: two proportion Z-test - HS versus MS and pre-clinical MS versus clinical MS.
Young men's knowledge of pathologies mimicking testicular cancer; data are shown as percentages of selected answers that agreed with statements regarding pathologies that can mimic TC.
| Other pathologies mimicking testicular cancer | HS (%) | MS (%) | Pre-clinical MS (%) | Clinical MS (%) | ||
|---|---|---|---|---|---|---|
| Orchitis | 57.3 | 42.5 | < 0.001 | 35.7 | 50.9 | < 0.001 |
| Spermatocele | 38.5 | 67.3 | < 0.001 | 70.5 | 63.1 | 0.039 |
| Varicocele | 11.3 | 40.7 | < 0.001 | 42.3 | 38.7 | 0.367 |
| Hydrocele | 35.8 | 49.7 | < 0.001 | 46.4 | 54.0 | 0.048 |
| Groin hernia | 19.4 | 21.6 | 0.468 | 23.9 | 18.6 | 0.097 |
| Twist of spermatic cord | 16.4 | 23.2 | 0.015 | 20.3 | 26.8 | 0.045 |
HS, high school students; MS, medical students.
p value: two proportion Z-test - HS versus MS and pre-clinical MS versus clinical MS.
Figure 2Young men's attitude towards testicular cancer self-examination; data are shown as a frequency of TSE.
Young men's altitude towards testicular cancer self-examination; data are shown as percentages of selected answers that agreed with statements regarding the reasons for not performing of TSE.
| Reasons for not performing testicular self-examination | HS (%) | MS (%) | Pre-clinical MS (%) | Clinical MS (%) | ||
|---|---|---|---|---|---|---|
| I do not know how to perform TSE | 63.0 | 45.6 | < 0.001 | 47.8 | 42.7 | 0.186 |
| TSE is irrelevant | 19.7 | 28.6 | 0.003 | 18.1 | 41.8 | < 0.001 |
| I am afraid of detecting cancer | 20.3 | 11.6 | < 0.001 | 11.1 | 12.2 | 0.732 |
| I am ashamed of performing TSE | 8.4 | 7.5 | 0.736 | 9.7 | 4.9 | 0.021 |
| Performing TSE is unethical | 6.9 | 5.5 | 0.470 | 4.6 | 6.7 | 0.275 |
HS, high school students; MS, medical students.
p value: two proportion Z-test - HS versus MS and pre-clinical MS versus clinical MS.